SNDL
SNDL
NASDAQ · Pharmaceuticals

Sndl Inc

$1.37
+0.01 (+0.74%)
As of Sep 20, 10:29 PM ET ·
Financial Highlights (FY 2026)
Revenue
919.49M
Net Income
-15,318,543
Gross Margin
27.3%
Profit Margin
-1.7%
Rev Growth
+9.9%
D/E Ratio
0.15
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 27.3% 27.3% 64.3% 64.3%
Operating Margin -0.8% -0.8% 39.2% 39.7%
Profit Margin -1.7% -1.6% 27.9% 35.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 919.49M 836.35M 59.12M 71.20M
Gross Profit 251.30M 228.58M 38.02M 45.80M
Operating Income -7,815,653 -6,398,115 23.17M 28.28M
Net Income -15,318,543 -12,540,193 16.50M 24.90M
Gross Margin 27.3% 27.3% 64.3% 64.3%
Operating Margin -0.8% -0.8% 39.2% 39.7%
Profit Margin -1.7% -1.6% 27.9% 35.0%
Rev Growth +9.9% +9.9% +13.8% -7.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 22.45M 22.45M 55.29M 58.47M
Total Equity 145.52M 145.52M 239.97M 225.54M
D/E Ratio 0.15 0.15 0.23 0.26
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 42.70M 36.89M 25.74M 34.11M
Free Cash Flow 14.78M 25.53M